VEXTF
Vext Science, Inc.
OTC Markets OTCQXUSDEQUITY
Healthcare
DELAYED
Sell
-55/100
Last price
0.15
▼ 0.01 (8.33%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.16
Day high
0.17
Day low
0.17
Volume
2.00K
Market cap
$36.54M
P/E (TTM)
—
52W range
0.10 – 0.32
Trailing performance
Returnvs SPY
1W
-11.36%
-13.2%
1M
-21.17%
-22.5%
3M
-8.89%
-12.2%
6M
-22.77%
-37.6%
YTD
-22.37%
-36.2%
1Y
-44.18%
-59.8%
3Y
-42.27%
-123.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on VEXTF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
113.17M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Dec 31, 25 | Phanos (Spiro Alexander) Director of Issuer |
— | 1.33M | — | Direct |
| Dec 31, 25 | Smith (Trevor) Senior Officer of Issuer |
SELL | 43.00K | $7.87K | Direct |
| Dec 30, 25 | Smith (Trevor) Senior Officer of Issuer |
SELL | 194.70K | $35.63K | Direct |
| Dec 29, 25 | Smith (Trevor) Senior Officer of Issuer |
SELL | 99.10K | $19.42K | Direct |
| Dec 26, 25 | Smith (Trevor) Senior Officer of Issuer |
SELL | 31.98K | $6.40K | Direct |
| Dec 24, 25 | Smith (Trevor) Senior Officer of Issuer |
SELL | 30.00K | $6.00K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Phanos (Spiro Alexander) |
Director of Issuer | 1.62M | Acquisition or disposition carried out privately |
Smith (Trevor) |
Senior Officer of Issuer | 587.01K | Acquisition or disposition in the public market |
Fundamentals
Market cap$36.54M
Enterprise value$65.77M
Revenue (TTM)$50.68M
Gross profit$19.74M
EBITDA$10.91M
Net income$-14.39M
EPS (TTM)$-0.06
Free cash flow$1.94M
Total cash$4.54M
Total debt$33.77M
Book value / share$0.22
Shares outstanding185.82M
Float101.67M
Short % of float—
Dividend yield0.00%
Beta (5Y)0.89
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.27
PEG ratio—
Price / sales—
Price / book0.67
EV / revenue1.30
EV / EBITDA6.03
Gross margin38.95%
Operating margin6.51%
Profit margin-28.39%
Return on equity-22.98%
Return on assets-1.82%
Debt / equity62.33
Current ratio0.97
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $51.37M | $36.00M | $34.81M | $35.41M | — | +42.7% |
| Operating revenue | $51.37M | $36.00M | $34.81M | $35.41M | — | +42.7% |
| Cost of revenue | $36.91M | $27.02M | $22.77M | $12.31M | — | +36.6% |
| Gross profit | $14.46M | $8.98M | $12.04M | $23.10M | — | +61.0% |
| Research & development | — | — | — | — | $150.06K | — |
| Selling, general & admin | $14.91M | $14.29M | $13.84M | $9.82M | — | +4.4% |
| Total operating expense | $21.40M | $20.16M | $19.88M | $13.82M | — | +6.1% |
| Operating income | -$6.94M | -$11.18M | -$7.84M | $9.28M | — | +37.9% |
| Net interest income | -$4.30M | -$3.71M | -$3.64M | -$1.94M | — | -16.0% |
| Pre-tax income | -$15.21M | -$21.12M | $3.36M | $6.70M | — | +28.0% |
| Tax provision | $2.78M | $1.31M | -$1.04M | -$4.22M | — | +111.7% |
| Net income | -$17.99M | -$22.43M | $4.40M | $10.92M | — | +19.8% |
| Net income to common | -$17.99M | -$22.43M | $4.40M | $10.92M | — | +19.8% |
| Basic EPS | -0.07 | -0.08 | 0.03 | 0.08 | — | +12.5% |
| Diluted EPS | -0.07 | -0.08 | 0.03 | 0.08 | — | +12.5% |
| EBIT | -$10.74M | -$17.20M | $7.17M | $8.75M | — | +37.6% |
| EBITDA | $5.14M | -$2.02M | $16.77M | $15.18M | — | +354.5% |
| Basic shares | 247.59M | 240.91M | 164.48M | 138.85M | — | +2.8% |
| Diluted shares | 247.59M | 240.91M | 164.74M | 139.53M | — | +2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.08M | $4.63M | $8.72M | $5.93M | +9.9% |
| Cash & short-term investments | $5.08M | $4.63M | $8.72M | $5.93M | +9.9% |
| Accounts receivable | $1.23M | $875.00K | $1.26M | $3.12M | +40.7% |
| Inventory | $7.47M | $13.32M | $13.26M | $13.76M | -43.9% |
| Total current assets | $16.78M | $20.81M | $35.93M | $51.93M | -19.3% |
| Property, plant & equipment | $38.55M | $39.47M | $41.17M | $36.45M | -2.3% |
| Goodwill & intangibles | $65.19M | $69.40M | $64.06M | $28.30M | -6.1% |
| Total assets | $120.53M | $136.97M | $149.56M | $120.52M | -12.0% |
| Total current liabilities | $28.49M | $20.28M | $16.40M | $15.73M | +40.5% |
| Current debt | $7.50M | $4.64M | $5.79M | $5.80M | +61.5% |
| Long-term debt | $23.51M | $31.08M | $30.05M | $31.46M | -24.4% |
| Total debt | $35.03M | $39.52M | $38.60M | $38.15M | -11.3% |
| Total liabilities | $65.16M | $63.65M | $56.99M | $48.60M | +2.4% |
| Retained earnings | -$5.12M | $12.87M | $35.31M | $33.32M | -139.8% |
| Shareholder equity | $55.37M | $73.32M | $92.57M | $71.92M | -24.5% |
| Working capital | -$11.71M | $532.00K | $19.54M | $36.19M | -2,301.1% |
| Net tangible assets | -$9.82M | $3.92M | $28.51M | $43.62M | -350.3% |
| Shares issued | 247.68M | 247.44M | 217.48M | 148.96M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$17.99M | -$22.43M | $4.40M | $10.92M | +19.8% |
| Depreciation & amortisation | $15.88M | $15.18M | $9.59M | $6.43M | +4.6% |
| Stock-based compensation | $47.00K | $696.00K | $384.61K | $1.45M | -93.2% |
| Change in working capital | $8.27M | -$1.43M | $4.40M | -$7.27M | +678.1% |
| Operating cash flow | $11.71M | $3.29M | $4.42M | $5.72M | +256.1% |
| Capital expenditure | -$3.57M | -$1.47M | -$2.74M | -$8.86M | -143.5% |
| Investing cash flow | -$5.66M | -$5.44M | -$4.82M | -$30.31M | -4.0% |
| Financing cash flow | -$5.60M | -$1.95M | $3.19M | $24.06M | -187.5% |
| Free cash flow | $8.14M | $1.82M | $1.69M | -$3.14M | +346.5% |
| End cash position | $5.08M | $4.63M | $8.72M | $5.93M | +9.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $12.12M | $12.16M | $13.73M | $12.67M | $13.41M | — | -0.3% |
| Operating revenue | $12.12M | $12.16M | $13.73M | $12.67M | $13.41M | — | -0.3% |
| Cost of revenue | $5.41M | $6.64M | $10.39M | $8.70M | $8.54M | — | -18.4% |
| Gross profit | $6.71M | $5.52M | $3.33M | $3.97M | $4.87M | — | +21.5% |
| Selling, general & admin | $4.51M | $4.11M | $6.72M | $3.04M | $3.77M | — | +9.7% |
| Total operating expense | $5.92M | $5.52M | $6.19M | $5.44M | $5.35M | — | +7.2% |
| Operating income | $789.00K | $0 | -$2.86M | -$1.47M | -$477.00K | — | — |
| Net interest income | -$825.00K | -$810.00K | -$2.00M | -$693.00K | -$889.00K | — | -1.9% |
| Pre-tax income | -$66.00K | -$643.00K | -$9.05M | -$2.87M | $264.00K | — | +89.7% |
| Tax provision | $249.00K | $249.00K | $1.50M | -$243.00K | $1.74M | — | 0.0% |
| Net income | -$315.00K | -$892.00K | -$10.56M | -$2.63M | -$1.48M | — | +64.7% |
| Net income to common | -$315.00K | -$892.00K | -$10.56M | -$2.63M | -$1.48M | — | +64.7% |
| Basic EPS | 0.00 | 0.00 | — | -0.01 | -0.01 | -0.01 | — |
| Diluted EPS | 0.00 | 0.00 | — | -0.01 | -0.01 | -0.01 | — |
| EBIT | $790.00K | $200.00K | -$7.01M | -$2.14M | $1.24M | — | +295.0% |
| EBITDA | $4.81M | $4.18M | -$3.00M | $1.87M | $5.35M | — | +15.0% |
| Basic shares | 247.69M | 247.68M | — | 247.62M | 247.58M | 247.49M | +0.0% |
| Diluted shares | 247.69M | 247.68M | — | 247.62M | 247.58M | 247.49M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.54M | $5.54M | $5.08M | $3.70M | $4.55M | -18.2% |
| Cash & short-term investments | $4.54M | $5.54M | $5.08M | $3.70M | $4.55M | -18.2% |
| Accounts receivable | $541.00K | $269.00K | $1.23M | $1.43M | $1.36M | +101.1% |
| Inventory | $11.40M | $8.57M | $7.47M | $9.62M | $10.25M | +33.0% |
| Total current assets | $27.06M | $17.00M | $16.78M | $16.30M | $17.81M | +59.1% |
| Property, plant & equipment | $28.83M | $36.95M | $38.55M | $38.81M | $40.18M | -22.0% |
| Goodwill & intangibles | $61.26M | $63.23M | $65.19M | $71.61M | $73.54M | -3.1% |
| Total assets | $117.15M | $117.18M | $120.53M | $128.09M | $132.88M | -0.0% |
| Total current liabilities | $27.98M | $27.32M | $28.49M | $17.25M | $18.99M | +2.4% |
| Current debt | $7.35M | $7.42M | $7.50M | $2.12M | $2.41M | -1.0% |
| Long-term debt | $22.44M | $22.72M | $23.51M | $29.65M | $29.31M | -1.2% |
| Total debt | $33.77M | $33.97M | $35.03M | $35.06M | $35.62M | -0.6% |
| Total liabilities | $62.97M | $62.69M | $65.16M | $59.68M | $61.84M | +0.5% |
| Retained earnings | -$6.33M | -$6.01M | -$5.12M | $7.85M | $10.47M | -5.2% |
| Shareholder equity | $54.18M | $54.49M | $55.37M | $68.41M | $71.04M | -0.6% |
| Working capital | -$916.00K | -$10.32M | -$11.71M | -$944.00K | -$1.18M | +91.1% |
| Net tangible assets | -$7.08M | -$8.74M | -$9.82M | -$3.20M | -$2.50M | +18.9% |
| Shares issued | 247.71M | 247.68M | 247.68M | 247.68M | 247.58M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$315.00K | -$892.00K | -$10.56M | -$2.63M | -$1.48M | +64.7% |
| Depreciation & amortisation | $4.02M | $3.98M | $4.02M | $4.01M | $4.11M | +1.0% |
| Stock-based compensation | $2.00K | $7.00K | -$5.00K | $10.00K | $17.00K | -71.4% |
| Change in working capital | -$1.12M | -$62.00K | $7.18M | $458.00K | $571.00K | -1,712.9% |
| Operating cash flow | $1.18M | $1.61M | $3.20M | $1.26M | $4.17M | -26.8% |
| Capital expenditure | -$1.43M | -$420.00K | -$850.00K | -$1.12M | -$780.00K | -239.3% |
| Investing cash flow | -$1.43M | -$420.00K | -$784.00K | -$1.10M | -$3.08M | -239.3% |
| Financing cash flow | -$764.00K | -$736.00K | -$1.03M | -$1.00M | -$1.37M | -3.8% |
| Free cash flow | -$243.00K | $1.20M | $2.35M | $136.00K | $3.40M | -120.3% |
| End cash position | $4.54M | $5.54M | $5.08M | $3.70M | $4.55M | -18.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.00 | 0.00 | 0.0% |
| Mar 2026 | -0.01 | 0.00 | +100.0% |
| Dec 2025 | -0.02 | -0.04 | -100.0% |
| Sep 2025 | -0.01 | -0.01 | -33.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.00 | 1 | $14.60M | +15.2% |
| Next quarter | 0.00 | 1 | $15.00M | +9.3% |
| Current year | 0.00 | 1 | $53.80M | +4.7% |
| Next year | 0.01 | 2 | $68.83M | +27.9% |
Analyst targets & ownership
Mean target$0.60
High target$0.60
Low target$0.60
Implied upside306.78%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders45.69%
Held by institutions0.35%
Institutions holding3
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.16
-9.29% from price
SMA 20
0.17
-15.69% from price
SMA 50
0.18
-19.63% from price
SMA 100
0.18
-19.75% from price
SMA 200
0.19
-22.61% from price
EMA 12
0.16
-10.27% from price
EMA 26
0.17
-15.10% from price
EMA 50
0.18
-17.78% from price
RSI (14)
36.0
Neutral
MACD (12,26,9)
-0.01
Hist -0.00
ATR (14)
0.01
9.29% of price
Realised vol 30D
102.3%
Annualised
Bollinger upper
0.20
20, 2σ
Bollinger lower
0.15
20, 2σ
50 / 200 cross
Death
0.18 vs 0.19
Trend bias
Below 200
-22.61%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.26
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
102.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-46.4%
Peak to trough
Max drawdown 5Y
-89.4%
Peak to trough
ATR 14
0.01
9.29% of price
Beta (reported)
0.89
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
Headlines
Vext Science Reopens Ohio Dispensary, Extends Maturity of Acquisition Notes to 2029
MT Newswires · 20d ago
Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
TMX Newsfile · 20d ago
Vext Provides Operational Update on Jackson, Ohio Dispensary
TMX Newsfile · 33d ago
Vext Science Inc (VEXTF) (Q2 2026) Earnings Call Highlights: Margin Expansion and Strategic ...
GuruFocus.com · 47d ago
Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter
TMX Newsfile · 48d ago
Vext Announces Date for Q2 2026 Financial Results Release
TMX Newsfile · 56d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.